"The discussion of delgocitinib and the presentation of DELTA FORCE data in The Lancet is an exciting moment for the LEO Pharma team," said Robert Spurr, EVP, LEO Pharma, North America and ...

“The discussion of delgocitinib and the presentation of DELTA FORCE data in The Lancet is an exciting moment for the LEO Pharma team,” said Robert Spurr, EVP, LEO Pharma, North America and ...

To learn more about CHE, visit www.TalkCHE.com. LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with ...

CHE is estimated to affect close to 5% of adults and can cause pain, itching, redness, blistering and swelling of the hands and wrists, among other symptoms, per Leo. “Given that we use our ...

LEO Pharma and the Parker Institute at Copenhagen University Hospital have entered into a three-year academic partnership aimed at advancing dermatology research. The alliance will focus on enhancing ...

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have approved a change to the terms of the marketing authorisation for LEO Pharma’s Adtralza ...

Microsoft is testing removing its name, i.e. Microsoft Bing, next to the logo in the Bing Search bar. Normally the search bar has the Microsoft Bing name next to the logo on the left side of the ...

16:01 EDT Vincerx Pharma (VINC) Inc trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

H.C. Wainwright lowered the firm’s price target on Innate Pharma (IPHA) to $11 from $11.50 and keeps a Buy rating on the shares. The firm postponed the U.S. launch of IPH6101 to 2029 from ...

BERLIN, April 25, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

Just a few months after buying Timber Pharma, LEO Pharma has revealed that the ... compared with patients treated with the ointment without isotretinoin. At the moment, treatment of congenital ...